Consultation closes: Concept paper: revision of biosimilar guideline (CHMP/437/04 Rev.1)
EMAConsultation deadline
High impact Past
Biosimilar developers and MAHs can comment on planned changes to EU data requirements for similar biological medicines.
Add to Google Calendar Subscribe to all dates (iCal)
Get the outcome, not just the date
When EMA publishes the final text, VigiEye subscribers get an AI summary of what changed versus the draft and who it affects.
Free weekly "EU regulatory week ahead" email. Or start monitoring.
Related upcoming dates
Dates are taken from the official source above. Agencies occasionally reschedule; confirm on the source before acting.